Afficher la notice abrégée

dc.contributor.editorCarpi, Angelo
dc.contributor.editorDonadio, Carlo
dc.contributor.editorTramonti, Gianfranco
dc.date.accessioned2021-04-20T15:13:05Z
dc.date.available2021-04-20T15:13:05Z
dc.date.issued2011
dc.identifierONIX_20210420_9789533073774_621
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/65264
dc.description.abstractHemodialysis (HD) represents the first successful long-term substitutive therapy with an artificial organ for severe failure of a vital organ. Because HD was started many decades ago, a book on HD may not appear to be up-to-date. Indeed, HD covers many basic and clinical aspects and this book reflects the rapid expansion of new and controversial aspects either in the biotechnological or in the clinical field. This book revises new technologies and therapeutic options to improve dialysis treatment of uremic patients. This book consists of three parts: modeling, methods and technique, prognosis and complications.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJQ Ophthalmologyen_US
dc.subject.otherRenal medicine & nephrology
dc.titleProgress in Hemodialysis
dc.title.alternativeFrom Emergent Biotechnology to Clinical Practice
dc.typebook
oapen.identifier.doi10.5772/878
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9789533073774
oapen.relation.isbn9789535165538
oapen.imprintIntechOpen
oapen.pages458


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/3.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/3.0/